A literature review on off-label drug use in children
Top Cited Papers
- 24 May 2005
- journal article
- review article
- Published by Springer Science and Business Media LLC in European Journal of Pediatrics
- Vol. 164 (9), 552-558
- https://doi.org/10.1007/s00431-005-1698-8
Abstract
The aim was to compare results of studies performed in different settings worldwide and identify common therapeutic areas to allow for focused interventions, because off-label drug use can be a measure of the lack of knowledge concerning paediatric treatments. A secondary objective was to provide a brief review of efforts to date. A literature review of articles on off-label and unlicensed drug use in children involving general prescription samples was performed using Medline and Embase. In all, 30 studies from 1985–2004 were included. Eleven involved paediatric hospital wards, seven neonatal hospital wards, and 12 the community setting. The off-label and unlicensed classification methods varied, making results difficult to compare. In general, off-label/unlicensed prescription rates ranged from 11%–80%, and higher rates were found in younger versus older patients and in the hospital versus community settings. On the paediatric hospital wards, off-label/unlicensed prescriptions ranged from 16%–62% and most often concerned acetaminophen, cisapride, chloral hydrate, and salbutamol. In the neonatal wards, rates ranged from 55%–80% and often involved caffeine. In the community setting, rates ranged from 11%–37% and the most commonly implicated drugs were salbutamol and amoxicillin. Conclusion:A lack of harmonisation between the evidence, the information available to doctors, and its use in clinical practice exists and this is part of the reason off-label therapies are so common. Attempts have been made to improve knowledge concerning paediatric treatments, but more focused interventions are needed, also taking into consideration this lack of harmonisation.Keywords
This publication has 74 references indexed in Scilit:
- Is it time for a European formulary of paediatric medicines?Archives of Disease in Childhood, 2004
- The Impact of Unlicensed and Off-Label Drug Use on Adverse Drug Reactions in Paediatric PatientsDrug Safety, 2004
- Research in childrenCritical Care Medicine, 2003
- Lack of effect of the European guidance on clinical investigation of medicines in childrenActa Paediatrica, 2002
- Unlicensed and Off-Label Drug Use in an Australian Neonatal Intensive Care UnitPEDIATRICS, 2002
- Unlicensed and Off-label Prescription of Systemic Anti-infective Agents to ChildrenPaediatric and Perinatal Drug Therapy, 2002
- Uses of Drugs Not Described in the Package Insert (Off-Label Uses)PEDIATRICS, 2002
- Unlicensed and off label prescription of drugs to children: population based cohort studyBMJ, 2002
- Off‐label use of drugs in Italy: a prospective, observational and multicentre studyActa Paediatrica, 2002
- Incidence des prescriptions hors autorisation de mise sur le marché en réanimation néonataleArchives de Pédiatrie, 2000